Zenotech Laboratories Stock Screener | Share Price & Fundamental Analysis
ZENOTECH
Pharmaceuticals
Screen Zenotech Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹48.32
▼
-0.68 (-1.39%)
Market Cap
₹282.95 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.89
EPS (TTM)
₹0.92
Dividend Yield
-
Debt to Equity
-
52W High
₹65.23
52W Low
₹44.23
Operating Margin
22.00%
Profit Margin
6.38%
Revenue (TTM)
₹47.00
EBITDA
₹16.00
Net Income
₹3.00
Total Assets
₹111.00
Total Equity
₹96.00
Zenotech Laboratories Share Price History - Stock Screener Chart
Screen ZENOTECH historical share price movements with interactive charts. Analyze price trends and patterns.
Zenotech Laboratories Company Profile - Fundamental Screener
Screen Zenotech Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENOTECH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE486F01012
Zenotech Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ZENOTECH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 111 | 106 | 101 | 94 | 86 | 86 | 85 | 82 | 51 | 53 |
| Current Assets | 36 | 26 | 16 | 7 | 7 | 6 | 19 | 31 | 2 | 3 |
| Fixed Assets | 61 | 66 | 65 | 71 | 74 | 49 | 43 | 44 | 47 | 48 |
| Liabilities | ||||||||||
| Total Liabilities | 111 | 106 | 101 | 94 | 86 | 86 | 85 | 82 | 51 | 53 |
| Current Liabilities | 2 | 2 | 2 | 8 | 23 | 1 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 96 | 91 | 82 | 71 | 48 | 50 | 39 | 42 | -66 | -46 |
| Share Capital | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 34 | 34 |
| Reserves & Surplus | 35 | 30 | 21 | 10 | -13 | -11 | -22 | -19 | -100 | -81 |
Screen ZENOTECH income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47 | 45 | 42 | 44 | 37 | 23 | 27 | 18 | 14 | 2 | 2 | 4 |
| Expenses | 31 | 29 | 24 | 22 | 19 | 16 | 17 | 17 | 19 | 13 | 10 | 24 |
| EBITDA | 16 | 16 | 18 | 22 | 18 | 7 | 10 | 1 | -6 | -10 | -8 | -20 |
| Operating Profit % | 22.00% | 33.00% | 42.00% | 49.00% | 48.00% | 28.00% | 35.00% | -27.00% | -71.00% | -462.00% | -373.00% | -492.00% |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 2 | 8 | 8 | 7 |
| Profit Before Tax | 9 | 11 | 11 | 15 | 10 | -1 | 11 | -3 | -12 | -20 | -19 | -30 |
| Tax | 1 | 5 | 3 | 3 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 3 | 6 | 8 | 12 | 22 | -1 | 11 | -3 | -12 | -20 | -19 | -30 |
| EPS | 0.50 | 0.92 | 1.36 | 1.90 | 3.63 | -0.20 | 1.77 | -0.51 | -2.24 | -5.77 | -5.56 | -8.83 |
Zenotech Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ZENOTECH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | 12 | 21 | 18 | 6 | 11 | -14 | -16 | 2 | -5 |
| Investing Activities | 15 | -21 | -6 | -2 | -5 | -21 | -16 | -3 | -1 | 6 |
| Financing Activities | 0 | 0 | -6 | -16 | 0 | -3 | 15 | 47 | -1 | -1 |
| Net Cash Flow | 25 | -9 | 9 | 0 | 1 | -12 | -15 | 28 | 0 | 0 |
Screen ZENOTECH shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% | 0.98% |
| Public Holding | 22.78% | 22.78% | 22.80% | 22.65% | 22.72% | 22.66% | 22.83% | 22.67% |
| Other Holding | 7.39% | 7.38% | 7.36% | 7.52% | 7.45% | 7.51% | 7.34% | 7.50% |
| Shareholder Count | 10,690 | 10,661 | 10,670 | 9,819 | 9,750 | 10,641 | 10,667 | 9,142 |
Zenotech Laboratories Dividend Screener - Share Yield Analysis
Screen ZENOTECH dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Zenotech Laboratories Index Membership - Market Screener Classification
Screen ZENOTECH by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Zenotech Laboratories Market Events Screener - Corporate Actions
Screen ZENOTECH market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.60% | ||
| Annual General Meeting | NA | 44.66% | ||
| Annual General Meeting | NA | -14.96% | ||
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 6.75% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | -0.16% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | -0.59% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -5.92% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -8.89% |
| 2017-06-01 | 2017-06-02 | Rights | 17:22 | - |
Zenotech Laboratories Competitors Screener - Peer Comparison
Screen ZENOTECH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Zenotech Laboratories Company Announcements - News Screener
Screen ZENOTECH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-31 | Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-31 | Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-22 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Board Meeting Outcome for Updation Of Address Of The Registered Office Of The Company | View |
| 2025-09-25 | Updation Of Address Of Registered Office Of The Company | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-01 | Notice Of 36Th Annual General Meeting Of Zenotech Laboratories Limited. | View |
| 2025-09-01 | Reg. 34 (1) Annual Report. | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-28 | Intimation Of 36Th Annual General Meeting Of Zenotech Laboratories Limited (The Company). | View |
| 2025-07-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On July 28 2025 | View |
| 2025-07-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On July 28 2025 | View |
| 2025-07-28 | Unaudited Financial Results For The Quarter Ended June 30 2025 | View |